Download full report with analyst certification and important disclosures
Feb 13 2025, 07:31 GMT
dsm-firmenich
EBITDA in line, buyback announced
- Sectors : Foods
- Companies : dsm-firmenich
DAVY VIEW
2024 was a year of progress for dsm-firmenich with 18% organic EBITDA growth led by cost savings and synergies. Q4 EBITDA was in line and its EBITDA outlook of ‘at least’ €2.4bn is largely consistent with current consensus. In light of recent asset disposals and an improvement in cash generation, the group has announced a €1bn buyback programme, which will run until Q2-26. We envisage no material change to our 2025 EBITDA forecast.
